CVSI
CV Sciences, Inc.
Key Financials
Revenue
$13.8M
↓ 12.2%
Operating Income
$-470000
↑ 78.5%
Net Income
$-958000
↑ 60.0%
Gross Profit
$6.8M
↓ 5.8%
Total Liabilities
$5.5M
↓ 10.4%
EPS (Diluted)
$-0.01
0.0%
Cash & Equivalents
$611000.00
↓ 55.6%
Total Assets
$7.0M
↓ 12.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CVSI |
| Company Name | CV Sciences, Inc. |
| CIK | 1510964 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 866-290-2157 |